In addition, several previous studies have demonstrated that both systemic and endothelial-specific PHD2 inhibition resulted in severe diseases such as idiopathic pulmonary hypertension and congestive heart failure in mice [35, 36]. The gene discussed is EGLN1; the disease is pulmonary arterial hypertension.